3 excellent ASX shares to buy for your SMSF

Analysts think these shares could be top picks for SMSF investors. Let's find out why.

| More on:
Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For Australia's growing community of self-managed super fund (SMSF) trustees, long-term thinking is everything.

With over 625,000 SMSFs holding a collective $990 billion in assets as of 30 June 2024, according to the ATO, more Australians than ever are taking control of their retirement outcomes — and doing so with an eye on quality, sustainability, and growth.

If you're managing your own super, choosing the right ASX shares can make a significant difference to your wealth over time.

The goal? Own companies with durable advantages, strong leadership, and clear growth runways that can compound for years to come.

With that in mind, here are three excellent ASX shares that analysts think could make strong long-term additions to any SMSF portfolio. They are as follows:

Goodman Group (ASX: GMG)

Goodman Group is a standout in the property space. Instead of shopping centres or office towers, it focuses on high-demand industrial assets like warehouses, distribution centres, and data infrastructure.

It is a pure play on the rise of e-commerce, supply chain modernisation, and the cloud economy. Major global names like Amazon and Microsoft are Goodman tenants, and the company has a development pipeline geared towards supporting data centre.

Citi currently rates Goodman as a buy with a $40.00 price target.

ResMed Inc. (ASX: RMD)

Another ASX SMSF share to look at is ResMed. It is a global leader in sleep and respiratory medicine, known for its innovative CPAP machines and digital health solutions. The company's technology helps millions of people around the world manage sleep apnoea and chronic respiratory conditions — and demand is only rising.

For SMSF investors looking to invest in healthcare innovation with global scale and recurring revenue, ResMed ticks all the boxes.

Goldman Sachs rates the company very highly. It has a conviction buy rating and $49.30 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for an SMSF. It has grown into one of Australia and New Zealand's biggest tech success stories — and there's still a long road ahead. The company provides cloud-based accounting software to just over 4 million subscribers globally, with deep penetration across ANZ and increasing traction in key international markets.

Xero generates recurring, high-margin revenue, and while it's still investing for growth, the business is now focused on profitability and operating leverage. Its customer base of small and medium businesses is loyal, sticky, and growing — making it a compelling software-as-a-service (SaaS) play for long-term investors.

Goldman Sachs estimates that it has a 100 million total addressable market. This gives it a significant growth runway over the next decade or two.

It is for this reason that Goldman has a buy rating and $201.00 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
Growth Shares

2 ASX shares to buy and hold for the next decade

These businesses have a lot of growth potential ahead…

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Growth Shares

Why these ASX 200 shares could still have major upside in 2026

Brokers think these shares could rise 20% to 45% in 2026.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

How I'd look for ASX growth shares today that could double my money

It might not be as hard as you think to achieve this.

Read more »

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Growth Shares

3 unstoppable ASX growth stocks to buy even if there's a stock market sell-off in 2026

Market volatility is uncomfortable, but some businesses are built to keep growing regardless of sentiment.

Read more »

A woman rides through an office on a scooter with a rocket strapped to her back as colleagues cheer.
Growth Shares

2 ASX growth shares set to skyrocket in 2026 and beyond

When sentiment turns, quality growth stocks often get dragged down.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Growth Shares

5 top ASX growth shares to buy now with $5,000

These shares are rated as buys by brokers. Here's what they are recommending.

Read more »

The hands of three people are cupped around soil holding three small seedling plants that are grouped together in the centre of the shot with the arms of the people extending into the edges of the picture representing ASX growth shares and it being a good time to buy for future gains
Dividend Investing

3 ASX shares that I rate as buys for both growth and dividends

These businesses could provide excellent total returns.

Read more »

A man peers into the camera looking astonished, indicating a rise or drop in ASX share price
Growth Shares

2 no-brainer Australian stocks to buy with $1,000 right now

Brokers believe these buy-rated shares could rise over 50% from current levels.

Read more »